Clinical Trial

Whole Body MRI in Oncology

Study acronym: ONCO-MRI
Recruiting
View on ClinicalTrials.gov →
Summary
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-19.
Trial Details
NCT Number NCT06895291
Lead Sponsor Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Conditions Lymphoma, Advanced Prostate Cancer, Advanced Breast Cancer, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, Multiple Myeloma
Enrollment 1,000 participants
Start Date 2023-10-26
Primary Completion 2028-10 (estimated)
Study Completion 2031-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-30